title: Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
abstract: The preliminary results of perfluorocytlbromide (PFOB) emulsion when used as an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.
authors.affiliation: Department of Radiology, Centre Antoine, Lacassagne, Nice, France.
authors.forename: J N
authors.initials: JN
authors.lastname: Bruneton
authors.forename: M N
authors.initials: MN
authors.lastname: Falewee
authors.forename: C
authors.initials: C
authors.lastname: Balu-Maestro
authors.forename: F
authors.initials: F
authors.lastname: Normand
authors.forename: R F
authors.initials: RF
authors.lastname: Mattrey
mesh_terms: D003287:Contrast Media; D005466:Fluorocarbons; D006801:Humans; D006842:Hydrocarbons, Brominated; D008099:Liver / Q000000981:diagnostic imaging*; D013154:Spleen / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; C003072:perflubron